(Q39501335)

12 September 2017

Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP). (English)

1 reference

non-small-cell lung carcinoma

12 September 2017

1 reference

1 reference

Qi Wang

1

1 reference

12 September 2017

Meizuo Zhong

2

1 reference

12 September 2017

Wei Liu

3

1 reference

12 September 2017

Jianhuang Li

4

1 reference

12 September 2017

Jin Huang

5

1 reference

12 September 2017

Le Zheng

6

1 reference

12 September 2017

25 July 2011

1 reference

Experimental Lung Research

12 September 2017

1 reference

12 September 2017

37

1 reference

12 September 2017

427-434

1 reference

12 September 2017

7

1 reference

12 September 2017

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNAs in development.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

A custom microarray platform for analysis of microRNA gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNA expression profiling of single whole embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

miR-138 might reverse multidrug resistance of leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Prediction of anticancer drug potency from expression of genes involved in growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Growth factor signaling and resistance to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Cisplatin and DNA repair in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

ERCC1 and clinical resistance to platinum-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902148.2011.584263

10.3109/01902148.2011.584263

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference